Advanced

The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men.

Vedder, Moniek M; de Bekker-Grob, Esther W; Lilja, Hans LU ; Vickers, Andrew J; van Leenders, Geert J L H; Steyerberg, Ewout W and Roobol, Monique J (2014) In European Urology 66(6). p.1109-1115
Abstract
Prostate-specific antigen (PSA) testing has limited accuracy for the early detection of prostate cancer (PCa).
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
European Urology
volume
66
issue
6
pages
1109 - 1115
publisher
Elsevier
external identifiers
  • pmid:25168616
  • wos:000344694300034
  • scopus:84910080750
ISSN
1873-7560
DOI
10.1016/j.eururo.2014.08.011
language
English
LU publication?
yes
id
b242d10e-35d8-463a-9e0d-16144ae25cdd (old id 4612742)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25168616?dopt=Abstract
date added to LUP
2014-09-09 19:28:42
date last changed
2017-11-05 03:02:18
@article{b242d10e-35d8-463a-9e0d-16144ae25cdd,
  abstract     = {Prostate-specific antigen (PSA) testing has limited accuracy for the early detection of prostate cancer (PCa).},
  author       = {Vedder, Moniek M and de Bekker-Grob, Esther W and Lilja, Hans and Vickers, Andrew J and van Leenders, Geert J L H and Steyerberg, Ewout W and Roobol, Monique J},
  issn         = {1873-7560},
  language     = {eng},
  number       = {6},
  pages        = {1109--1115},
  publisher    = {Elsevier},
  series       = {European Urology},
  title        = {The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men.},
  url          = {http://dx.doi.org/10.1016/j.eururo.2014.08.011},
  volume       = {66},
  year         = {2014},
}